The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
Open accessAbstract
Significance: Medicinal cannabis use is booming despite limited preclinical evidence and mechanistic insight. Recent clinical trials of cannabidiol (CBD) in Dravet syndrome (DS) support its clinical efficacy for reduction of seizure frequency and invite study of its benefits for additional DS symptoms. We demonstrate here that treatment with CBD is beneficial for seizure frequency, duration, and severity and for autistic-like social deficits in a mouse model of DS. CBD rescue of DS symptoms is associated with increased inhibitory neurotransmission, potentially mediated by antagonism of the lipid-activated G protein-coupled receptor GPR55. These studies lend critical support for treatment of seizures in DS with CBD, extend the scope of CBD treatment to autistic-like behaviors, and provide initial mechanistic insights into CBD’s therapeutic actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,171
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · cited 3×
“It has been shown that CBD antagonizes GPR55 activity in transfected cells (36), and our results extend these findings to intact neurons in brain slices.”
BackgroundResultYu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173 · cited 8×
“Scn1a mice (DS mice) are a well-defined phenocopy of human DS (13, 14), as they exhibit both thermally induced and spontaneous seizures (13, 15) and autism-like social deficits (16, 17).”
BackgroundInfluentialSelf-citationGuide for the Care and Use of Laboratory Animals: Eighth Edition -- Tamil Version
Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Studies, D. O. E. A. L., & National Research Council (2011) · National Academies Press eBooks · doi:10.17226/25801 · Cited by 1,118
Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“Seizure severity was assessed based on the Racine Scale scoring system (46): (1) mouth and facial movements; (2) head nodding; (3) forelimb clonus, usually one limb; (4) forelimb clonus with rearing; and (5) Generalized tonic-clonic seizure, rearing, clonus, and falling.”
MethodCannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00379-8 · Cited by 900
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879 · cited 4×
“Scn1a mice (DS mice) are a well-defined phenocopy of human DS (13, 14), as they exhibit both thermally induced and spontaneous seizures (13, 15) and autism-like social deficits (16, 17).”
BackgroundInfluentialAutistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission
Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., Rubenstein, J. L., Scheuer, T., de la Iglesia, H. O., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11356 · Cited by 643
Self-citationThe core Dravet syndrome phenotype
Dravet, C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02994.x · Cited by 627
Mechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., Woodcock, H., Dorward, P., Pigliacampo, B., Close, S., et al. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2415-0 · Cited by 398
Cheah, C. S., Yu, F. H., Westenbroek, R. E., Kalume, F. K., Oakley, J. C., Potter, G. B., Rubenstein, J. L., & Catterall, W. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211591109 · Cited by 336 · cited 4×
“1 channels in forebrain GABAergic interneurons recapitulated the DS phenotype and established that hypoexcitability of these interneurons is sufficient to cause the epileptic phenotype (21) and autistic-like behaviors (16) observed in DS mice.”
BackgroundInfluentialSelf-citationMandillo, S., Tucci, V., Hölter, S. M., Meziane, H., Banchaabouchi, M. A., Kallnik, M., Lad, H. V., Nolan, P. M., Ouagazzal, A.-M., Coghill, E. L., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90207.2008 · Cited by 282
Sudden unexpected death in a mouse model of Dravet syndrome
Kalume, F., Westenbroek, R. E., Cheah, C. S., Yu, F. H., Oakley, J. C., Scheuer, T., & Catterall, W. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66220 · Cited by 282
Self-citationDravet syndrome: The long‐term outcome
Genton, P., Velizarova, R., & Dravet, C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03001.x · Cited by 266
Kalume, F., Yu, F. H., Westenbroek, R. E., Scheuer, T., & Catterall, W. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2162-07.2007 · Cited by 261
Self-citationCannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
Jones, N. A., Glyn, S. E., Akiyama, S., Hill, T. D. M., Hill, A. J., Weston, S. E., Burnett, M. D. A., Yamasaki, Y., Stephens, G. J., Whalley, B. J., et al. (2012) · Seizure · doi:10.1016/j.seizure.2012.03.001 · Cited by 248
Ohlsson, A., Lindgren, J.-E., Andersson, S., Agurell, S., Gillespie, H., & Hollister, L. E. (1986) · Biological Mass Spectrometry · doi:10.1002/bms.1200130206 · Cited by 239
Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy
Oakley, J. C., Kalume, F., Yu, F. H., Scheuer, T., & Catterall, W. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813330106 · Cited by 239
Self-citationHan, S., Tai, C., Jones, C. J., Scheuer, T., & Catterall, W. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.016 · Cited by 231
Self-citationTranslational animal models of autism and neurodevelopmental disorders
Crawley, J. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/jcrawley · Cited by 230
In vivo evaluation of the dentate gate theory in epilepsy
Krook‐Magnuson, E., Armstrong, C., Bui, A., Lew, S., Oijala, M., & Soltesz, I. (2015) · The Journal of Physiology · doi:10.1113/jp270056 · Cited by 218
Sylantyev, S., Jensen, T. P., Ross, R. A., & Rusakov, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211204110 · Cited by 213
Hill, T. D. M., Cascio, M., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 187
Ogiwara, I., Iwasato, T., Miyamoto, H., Iwata, R., Yamagata, T., Mazaki, E., Yanagawa, Y., Tamamaki, N., Hensch, T. K., Itohara, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt331 · Cited by 186
Mistry, A. M., Thompson, C. H., Miller, A. R., Vanoye, C. G., George, & Kearney, J. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.006 · Cited by 179
Dissecting the phenotypes of Dravet syndrome by gene deletion
Rubinstein, M., Han, S., Tai, C., Westenbroek, R. E., Hunker, A. C., Scheuer, T., & Catterall, W. A. (2015) · Brain · doi:10.1093/brain/awv142 · Cited by 144
Self-citationAberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol
Patel, R. R., Barbosa, C., Brustovetsky, T., Brustovetsky, N., & Cummins, T. (2016) · Brain · doi:10.1093/brain/aww129 · Cited by 136
Trends in registered medical marijuana participation across 13 US states and District of Columbia
Fairman, B. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.11.015 · Cited by 122
Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome
Kalume, F. K., Oakley, J. C., Westenbroek, R. E., Gile, J. J., de la Iglesia, H. O., Scheuer, T., & Catterall, W. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.016 · Cited by 116
Self-citationIto, S., Ogiwara, I., Yamada, K., Miyamoto, H., Hensch, T. K., Ōsawa, M., & Yamakawa, K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.003 · Cited by 116
Kargl, J., Brown, A. J., Andersen, L., Dorn, G., Schicho, R., Waldhoer, M., & Heinemann, Á. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204180 · Cited by 105
Rubinstein, M., Westenbroek, R. E., Yu, F. H., Jones, C. J., Scheuer, T., & Catterall, W. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.017 · Cited by 100
Self-citationUnexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
Anderson, L. L., Hawkins, N. A., Thompson, C. H., Kearney, J. A., & George, A. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-01851-9 · Cited by 90
Normal and epilepsy-associated pathologic function of the dentate gyrus
Dengler, C. G., & Coulter, D. A. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.04.005 · Cited by 80
Hawkins, N. A., Zachwieja, N. J., Miller, A. R., Anderson, L. L., & Kearney, J. A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006398 · Cited by 74
Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model
Straiker, A. J., Mitjavila, J., Yin, D., Gibson, A. S., & Mackie, K. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.017 · Cited by 73
Gallop, K., Wild, D. J., Nixon, A., Verdian, L., & Cramer, J. A. (2009) · Seizure · doi:10.1016/j.seizure.2009.06.005 · Cited by 65
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity
Hurst, K., Badgley, C., Ellsworth, T. S., Bell, S., Friend, L. N., Prince, B., Welch, J., Cowan, Z., Williamson, R., Lyon, C., et al. (2017) · Hippocampus · doi:10.1002/hipo.22747 · Cited by 63
Autism and behavior in adult patients with Dravet syndrome (DS)
Berkvens, J. J. L., Veugen, I., Veendrick-Meekes, M. J. B. M., Snoeijen-Schouwenaars, F. M., Schelhaas, H. J., Willemsen, M. H., Tan, I. Y., & Aldenkamp, A. P. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.057 · Cited by 60 · cited 2×
“Moreover, the ensuing social impairment associated with DS adds an additional burden of care and increases risk for accidents and premature death (9, 10).”
BackgroundLee, C.-T., Kao, M.-H., Hou, W., Wei, Y.-T., Chen, C., & Lien, C. (2016) · Scientific Reports · doi:10.1038/srep36885 · Cited by 57
Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
Oakley, J. C., Cho, A. R., Cheah, C. S., Scheuer, T., & Catterall, W. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203331 · Cited by 56
Self-citationBarahmand, U., & Haji, A. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.07.002 · Cited by 51
Cited by
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 741
Mechanisms of action of currently used antiseizure drugs
Sills, G. J., & Rogawski, M. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107966 · Cited by 489
De Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 282
Metadata
- Authors
- Kaplan, J. S., Stella, N., Catterall, W. A., & Westenbroek, R. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-10-02
- Volume
- 114
- Issue
- 42
- Pages
- 11229-11234
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2761862301
- Cited by
- 378
- References
- 47
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.